28 results
S-8
EX-5.1
LRMR
Larimar Therapeutics Inc
2 Oct 20
Registration of securities for employees
5:19pm
as Exhibit 5.1 to the Registration Statement. In giving this consent, we do not thereby admit that we are an “expert” within the meaning
8-K
EX-5.1
LRMR
Larimar Therapeutics Inc
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
under the heading “Legal Matters” in the Prospectus. In rendering this opinion and giving this consent, we do not admit that we are an “expert
S-8
EX-5.1
LRMR
Larimar Therapeutics Inc
26 Jun 20
Registration of securities for employees
5:28pm
Statement. In rendering this opinion and giving this consent, we do not admit that we are an “expert” within the meaning of the Securities Act or the rules
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
7 Jun 18
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
5:06pm
Exhibit 99.1
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
Zafgen, Inc. also
8-K
EX-99.1
i68nrp myb
7 Aug 18
Zafgen Reports Second Quarter 2018 Operating and Financial Results
4:21pm
10-K/A
isoqgdqki5rmx ts3a
29 Apr 16
Annual report (amended)
12:00am
8-K
EX-10.3
bsh8i
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
PRE 14A
donoxr553s 3f
12 Apr 24
Preliminary proxy
6:06am
S-1
EX-10.1
49dmu2hd6umy517je8s
18 Apr 14
IPO registration
12:00am
PREM14A
2pqbd
6 Mar 20
Preliminary proxy related to merger
5:32pm
PRER14A
ycnt4d348rok3a6q 1o1
10 Apr 20
Preliminary revised proxy
4:38pm
DEFM14A
wbk66f2dhcco8
29 Apr 20
Proxy related to merger
3:20pm